Consistent with these studies, we found that SOX18-siRNA treatment significantly decreased the migration and invasion capabilities of the HCC cells (Fig. 3), which suggest the role of SOX18 in promoting the metastasis of HCC. The gene discussed is SOX18; the disease is hepatocellular carcinoma.